Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Hepatitis

  Free Subscription


28.09.2026

3 Clin Infect Dis
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
2 J Med Virol
5 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
1 Nature
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Clin Infect Dis

  1. BERHE N, Desalegn H, Mengistu H, Birhane D, et al
    Effectiveness of timely hepatitis B birth dose vaccination to prevent mother-to-child transmission in Ethiopia.
    Clin Infect Dis. 2026 Sep 24:ciag598. doi: 10.1093.
    PubMed         Abstract available

  2. LOK AS
    Critical role of hepatitis B birth dose vaccination in preventing mother-to-child transmission.
    Clin Infect Dis. 2026 Sep 24:ciag599. doi: 10.1093.
    PubMed        

  3. SIMONSON R, Koenigsberg B, Gonzalez Varela N, Wiersema J, et al
    Gender Differences in Hepatitis C Care Outcomes in the New York City Jail System, 2019-2023: A Retrospective Cohort Study.
    Clin Infect Dis. 2026 Sep 22:ciag480. doi: 10.1093.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  4. ZHU L, Jin Q, Han G
    The effect of tenofovir alafenamide fumarate on lipid profiles in pregnant women with hepatitis B virus.
    Eur J Gastroenterol Hepatol. 2026 Sep 9. doi: 10.1097/MEG.0000000000003281.
    PubMed         Abstract available


    Gastroenterol Hepatol

  5. BUTI M, Aguilera A, Calleja JL, Molero JM, et al
    Corrigendum to "Recommendations for the diagnosis of patients with hepatitis delta virus (HDV) in Spain [Gastroenterologia y Hepatologia 49 (2026) 502768]".
    Gastroenterol Hepatol. 2026 Sep 21:502848. doi: 10.1016/j.gastrohep.2026.502848.
    PubMed        


    Gastroenterology

  6. WONG TCL, Chan ACY, Fung JYY
    Sustained safety and efficacy of entecavir monotherapy for chronic hepatitis B after liver transplantation: 15-year follow-up.
    Gastroenterology. 2026 Sep 21:S0016-5085(26)07254.
    PubMed        


    Hepatology

  7. LAMMERT CS, Weinberg EM, Sclair SN, Fontana RJ, et al
    Safety and efficacy of zetomipzomib in relapsed or insufficiently responding autoimmune hepatitis: Results from the randomized, double-blind, placebo-controlled, phase 2a PORTOLA study and open-label extension.
    Hepatology. 2026 Aug 26. doi: 10.1097/HEP.0000000000001840.
    PubMed         Abstract available


    J Med Virol

  8. VLADIMIRSKY SN, Degiuseppe JI, Otegui LO, Brajterman LS, et al
    Seroprevalence and Associated Factors of Hepatitis A Virus and Hepatitis E Virus Infection Among Blood Donors in Argentina: A Multicentre Study.
    J Med Virol. 2026;98:e71157.
    PubMed         Abstract available

  9. MARTIN-PORTUGUES M, Esteban-Sampedro J, Munoz-Serrano A, Vicente-Lopez N, et al
    Hospital Admissions for Hepatitis A and E in Spain: Nationwide Trends and In-Hospital Outcomes.
    J Med Virol. 2026;98:e71159.
    PubMed         Abstract available


    J Viral Hepat

  10. ROSSOTTI R, Tavelli A, Malagnino V, Svicher V, et al
    Persistent ALT Elevation and Liver Outcomes After DAA-Induced HCV Cure in People With HIV: Impact of HBV and HDV Co-Infections.
    J Viral Hepat. 2026;33:e70230.
    PubMed         Abstract available

  11. FATIMA N, Elle A
    Beyond Virological Response: Refining the Assessment of Clinical and Patient-Reported Outcomes in Bulevirtide Therapy for Chronic Hepatitis D.
    J Viral Hepat. 2026;33:e70233.
    PubMed        

  12. ZHANG X, Yue C
    Interpreting Risk Factors in Hepatitis C Virus-Associated Hepatocellular Carcinoma.
    J Viral Hepat. 2026;33:e70231.
    PubMed        

  13. ETOORI D, Powell A, Trembling P, Plunkett J, et al
    Estimating the Fraction of Hepatocellular Carcinoma and Decompensated Cirrhosis Attributable to Viral Hepatitis in England Using Electronic Health Records and Case-Notes Review.
    J Viral Hepat. 2026;33:e70228.
    PubMed         Abstract available

  14. BRASIL S, Ribeiro-Alves M, Villela-Nogueira C, Silva SDCC, et al
    Optimizing the HCV Care Continuum in Primary Care: Opportunistic Screening With Point-Of-Care RNA Testing and Immediate Linkage-To-Care in Rio de Janeiro, Brazil.
    J Viral Hepat. 2026;33:e70234.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  15. LINWONG NN, Etienne MK, Llau A, Menke S, et al
    Hepatitis A Outbreak Associated with Cuba - Florida, June 2024-February 2026.
    MMWR Morb Mortal Wkly Rep. 2026;75:567-572.
    PubMed         Abstract available


    N Engl J Med

  16. WANG Y, Fan L, Zhang Z, Chen X, et al
    Oya Virus in a Patient with Severe Hepatitis, Enteritis, and Coagulopathy.
    N Engl J Med. 2026;395:1244-1246.
    PubMed        

  17. LUO S, Jin W, Liu H
    Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
    N Engl J Med. 2026;395:1246-1247.
    PubMed        

  18. CHEN EQ
    Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
    N Engl J Med. 2026;395:1247.
    PubMed        

  19. HOU J, Lim SG, Elston R
    Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection. Reply.
    N Engl J Med. 2026;395:1247.
    PubMed        


    Nature

  20. NADDAF M
    'Epigenetic' editing is here: gene-tagging technique banishes hepatitis B virus.
    Nature. 2026 Sep 21. doi: 10.1038/d41586-026-02981.
    PubMed        


    PLoS One

  21. BIELLO KB, Bazzi AR, Dunham K, Goldman JE, et al
    Responding to the increase in substance use, HIV, HCV, and overdose in New England (RISE-NE): Protocol for a prospective cohort study.
    PLoS One. 2026;21:e0358938.
    PubMed         Abstract available

  22. TUFAEL D, Mujahid MH, Akter MF, Salam T, et al
    The role of insulin resistance in the development of hepatocellular carcinoma with computational analysis of IRS-1 interaction with HCV genotype 3 core protein.
    PLoS One. 2026;21:e0358858.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum